Prostate cancer is the second most common cancer among men. Until 2012, the screening for prostate cancer, called the Prostate-Specific Antigen (PSA) test, was the standard for predicting prostate cancer for men 55 and older. Because PSA is a protein produced by both cancerous and noncancerous tissue in the prostate, it was determined to be […]